Merck leaps into COVID-19 development fray with vaccine, drug deals
CHICAGO (Reuters) - Merck & Co Inc (MRK.N), which has largely kept to the sidelines of the race for COVID-19 treatments, said it was buying Austrian vaccine maker Themis Bioscience…